Sign In
Buy NMRA
$1.61
+0.0100 (+0.625%)
At Close: Aug 05, 2026
Investors in Neumora Therapeutics, Inc. Should Contact Levi & Korsinsky Before April 7, 2025 to Discuss Your Rights - NMRA
02:30pm, Monday, 17'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 17, 2025 / If you suffered a loss on your Neumora Therapeutics, Inc. (NASDAQ:NMRA) investment and want to learn about a potential recovery under the federal s
NEW YORK, NY / ACCESS Newswire / February 17, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the common stock of Neumora Therapeutics, Inc.(NASDAQ:NMRA) pursuant
NEW YORK, NY / ACCESS Newswire / February 17, 2025 / If you suffered a loss on your Neumora Therapeutics, Inc. (NASDAQ:NMRA) investment and want to learn about a potential recovery under the federal s
Investors in Neumora Therapeutics, Inc. Should Contact Levi & Korsinsky Before April 7, 2025 to Discuss Your Rights - NMRA
11:30am, Monday, 17'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 17, 2025 / If you suffered a loss on your Neumora Therapeutics, Inc. (NASDAQ:NMRA) investment and want to learn about a potential recovery under the federal s
Class Action Filed Against Neumora Therapeutics, Inc. (NMRA) Seeking Recovery for Investors - Contact Levi & Korsinsky
04:22pm, Sunday, 16'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 16, 2025 / If you suffered a loss on your Neumora Therapeutics, Inc. (NASDAQ:NMRA) investment and want to learn about a potential recovery under the federal s
RADNOR, PA / ACCESS Newswire / February 16, 2025 / The law firm of Kessler Topaz Meltzer & Check, LLP(www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Neum
Class Action Filed Against Neumora Therapeutics, Inc. (NMRA) Seeking Recovery for Investors - Contact Levi & Korsinsky
11:45am, Sunday, 16'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 16, 2025 / If you suffered a loss on your Neumora Therapeutics, Inc. (NASDAQ:NMRA) investment and want to learn about a potential recovery under the federal s
The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against Neumora Therapeutics, Inc.
11:00am, Sunday, 16'th Feb 2025
LOS ANGELES, CA / ACCESS Newswire / February 16, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Neumora Therapeutics,
Contact Levi & Korsinsky by April 7, 2025 Deadline to Join Class Action Against Neumora Therapeutics, Inc. (NMRA)
09:00am, Sunday, 16'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 16, 2025 / If you suffered a loss on your Neumora Therapeutics, Inc. (NASDAQ:NMRA) investment and want to learn about a potential recovery under the federal s
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Neumora Therapeutics
08:16am, Sunday, 16'th Feb 2025
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Neumora To Contact Him Directly To Discuss Their Options If you purchased or acquired
Lost Money on Neumora Therapeutics, Inc. (NMRA)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
08:00am, Sunday, 16'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 16, 2025 / If you suffered a loss on your Neumora Therapeutics, Inc. (NASDAQ:NMRA) investment and want to learn about a potential recovery under the federal s
NEW YORK, NY / ACCESS Newswire / February 16, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Neumora
Levi & Korsinsky Notifies Neumora Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - NMRA
10:17pm, Saturday, 15'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 15, 2025 / If you suffered a loss on your Neumora Therapeutics, Inc. (NASDAQ:NMRA) investment and want to learn about a potential recovery under the federal s
NEW YORK, NY / ACCESS Newswire / February 15, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the common stock of Neumora Therapeutics, Inc.(NASDAQ: NMRA) pursuant
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Neumora Therapeutics, Inc.(NMRA) Shareholders
06:01pm, Saturday, 15'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 15, 2025 / If you suffered a loss on your Neumora Therapeutics, Inc. (NASDAQ:NMRA) investment and want to learn about a potential recovery under the federal s
